![J.P. Steve Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 335 720 $ op 31-07-2026
J.P.
Steve Hsu is the founder of Genovior Biotech Corp., founded in 2015, serving as Chairman & Chief Executive Officer since 2015.
Former job includes Chief Executive Officer at Polaris Group from 2023 to 2025.
Education includes a doctorate from the Massachusetts Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
POLARIS GROUP 0,11% | 23-03-2025 | 1.000.000 ( 0,11% ) | 335 720 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Genovior Biotech Corp.
 Genovior Biotech Corp. BiotechnologyHealth Technology Operates as contract development and manufacturing organization | Algemeen Directeur | 01-01-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
| POLARIS GROUP | Algemeen Directeur | 24-12-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Polaris Group
 Polaris Group BiotechnologyHealth Technology Engages in research and development of protein drugs to treat cancer and other debilitating diseases in humans | Health Technology |
Genovior Biotech Corp.
Genovior Biotech Corp. BiotechnologyHealth Technology Operates as contract development and manufacturing organization | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
